← All companies
PRAX
Praxis Precision Medicines, Inc.
$310.07
+4.56 +1.49%
Key statistics
from XBRL data in SEC filingsMarket cap
$8.64B
Revenue (TTM)
$0.00
Net income (TTM)
-$326M
EPS (TTM)
$-13.39
P/E ratio
—
Dividend yield
—
Free cash flow
-$249M
Cash
$536M
Total assets
$1.46B
Gross margin
—
52-week range
$37.19 – $366.52
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 7, 2026
8-K
Changed accountants
Jul 2, 2026
8-K
Other events
Jun 29, 2026
8-K
Other events
Jun 22, 2026
8-K
Shareholder vote results
Jun 12, 2026
8-K
Other events
Jun 1, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Other events
Apr 14, 2026
8-K
Other events
Apr 6, 2026
10-K
Fiscal year ended 2025-12-31
Feb 19, 2026
8-K
Results of operations (earnings release)
Feb 19, 2026
8-K/A
Director or officer change
Feb 10, 2026
8-K
Director or officer change
Jan 8, 2026
8-K
Other events
Jan 7, 2026
8-K
Results of operations (earnings release)
Jan 6, 2026
8-K
Other events
Dec 29, 2025
8-K
Other events
Dec 11, 2025
8-K
Other events
Dec 8, 2025
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Results of operations (earnings release)
Nov 5, 2025
8-K
Regulation FD disclosure; Other events
Oct 21, 2025
8-K
Other events
Oct 20, 2025
8-K
Regulation FD disclosure; Other events
Oct 16, 2025
8-K
Other events
Sep 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Aug 4, 2025
10-Q
Quarter ended 2025-06-30
Aug 4, 2025
8-K
Regulation FD disclosure; Other events
Jul 17, 2025
8-K
Shareholder vote results
Jun 27, 2025
8-K
Regulation FD disclosure; Other events
May 2, 2025
10-Q
Quarter ended 2025-03-31
May 2, 2025
8-K
Results of operations (earnings release)
May 2, 2025
10-K
Fiscal year ended 2024-12-31
Feb 28, 2025
8-K
Results of operations (earnings release)
Feb 28, 2025
8-K
Results of operations (earnings release)
Jan 29, 2025
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 6, 2024
8-K
Director or officer change
Oct 15, 2024
8-K
Regulation FD disclosure; Other events
Sep 3, 2024
10-Q
Quarter ended 2024-06-30
Aug 13, 2024